New Intrinsically Thermostable Xylanase Improves Broilers’ Growth Performance, Organ Weights, and Affects Intestinal Viscosity and pH

Abstract

Exogenous carbohydrases are commonly added to monogastric animal feed to degrade non-starch polysaccharides (NSP) to improve zootechnical performance and nutrient digestion. In the current study, the effects of dietary supplementation of a new, intrinsically thermostable, monocomponent xylanase on intestinal parameters, zootechnical performance and carcass traits of broilers were evaluated. A total of 720 1-day-old broilers were randomly allotted to four wheat-based diets with different levels of xylanase (T1: control; T2: 30,000 U/g; T3: 45,000 U/g; T4: 90,000 U/g) and fed from 1 to 35 days of age. The data showed that xylanase supplementation reduced the intestinal viscosity significantly, especially in the ileum. Duodenum and cecum pH was not influenced by xylanase supplementation, while T3 treatment showed the lowest pH value in jejunum and ileum. Xylanase supplementation reduced significantly feed conversion ratio (FCR) without affecting feed intake (FI). T2 treatment exhibited a higher body weight gain (BWG) compared the other treatments. Live weight, carcass weight, legs, and liver weight were significantly higher in T3 and T4 treatments compared to T1. No significant differences on foot pad lesions were observed among the four treatments. In conclusion, dietary supplementation of this new xylanase significantly improves intestinal tract viscosity and affects beneficially broilers’ performance and carcass traits.

1. Introduction

Reducing costs of feed production is a challenging issue for the poultry industry. Due to the increase in grain prices, the animal feed industry has been working towards lowering nutritional costs [1]. Due to shortage of corn supply and the increase of corn price, wheat has become an important source of energy in poultry diets because of. However, the utilization efficiency of wheat is lower than that of corn because it contains more anti-nutritive factors, especially non-starch polysaccharides (NSP). Wheat contains arabinoxylans, which are the major NSP fractions. The latter reduce the digestibility of nutrients and decrease the feed efficiency and growth performance when fed to poultry, especially in broiler chickens [2,3,4]. The anti-nutritive effect of NSPs is instigated by the increase of the viscosity of the intestinal digesta [5,6,7,8]. This increase in digesta viscosity jeopardizes nutrient bioavailability and decreases metabolizable energy which lowers the overall performance of animals fed on wheat-based diets [9,10]. Moreover, dietary NSP can also facilitate small intestinal fermentation by modulating the intestinal microflora [11,12], which might be detrimental to nutrient digestion and absorption for chickens [13].

Poultry have no production of endogenous carbohydrases capable of hydrolyzing the pentosan NSPs, such as the arabinoxylans, present in viscous cereals. Therefore, dietary supplementation of exogenous enzymes has proven to be a state-of-the-art cost-saving mechanism [1]. Exogenous enzymes can hydrolyze NSP, which improves the digestibility and utilization of nutrients. Xylanases are the major enzymes involved in arabinoxylan degradation, hydrolyzing the 1,4-β-D-xylosidic linkage between xylose residues in the backbone in a random manner [14]. Xylanase has been widely added to commercial wheat-based compound feeds for broilers and it is believed that these enzymes break down polysaccharide cage structures around proteins. The use of exogenous enzymes such as xylanase is a key component of broiler diets for efficient utilization of feed ingredients, down-grading production costs and improvement of performance indexes [1].

It is well documented that addition of NSP hydrolyzing enzymes to cereal-based diets is one of the major strategies to improve growth performance and nutrient digestion in broiler chickens. Supplementing feed with xylanase has been shown to improve nutrient digestibility and concomitantly preserve good gut health by allowing fewer nutrients to be available in the animal’s gut for the potential growth of disease-causing bacteria [15,16,17,18]. This supplementation facilitates animal performance, with improved absorption of feed components and a greater efficiency in meat and egg production [19,20,21]. Furthermore, previous studies have demonstrated that addition of xylanases in wheat-based diets can reduce the intestinal viscosity by partially hydrolyzing NSPs of wheat. The latter results in improvements in nutrient digestibility and growth performance of broilers [22,23,24]. Moreover, other studies showed that xylanase supplementation of a wheat-based diet improved chicken immunity [23], reduced detrimental effect after Salmonella Typhimurium infection [25], or alleviated the intestinal mucosal barrier impairment of broiler chickens challenged by Clostridium perfringens [26].

A recently developed enzyme (Xygest^TM HT) is a thermostable xylanase produced by Thermopolyspora flexuosa (Pichia yeast) and is a beta 1-4, endo-xylanase enzyme. Its use has been investigated in corn-based diets, which resulted in improved broiler performance and nutrient digestibility and promoted Lactobacilli growth [27]. However, no information is available so far on its efficacy in wheat-based diets. Based on the described effects of xylanases in wheat enriched broiler diets, it was hypothesized that the latter thermostable one could improve broiler growth performance, carcass yield, reduce intestinal viscosity and pH and influence positively foot pad dermatitis scoring when supplemented at different levels. The objective of the present study was to evaluate the efficacy of the new thermostable xylanase produced by Thermopolyspora flexuosa (Pichia yeast) in wheat-based broilers’ diets, when supplemented at 30,000 U/g (10 g/t), 45,000 U/g (15 g/t), and 90,000 U/g (30 g/t).

2. Materials and Methods

2.1. Xylanase Product

Xygest^TM HT (Kemin Animal Nutrition and Health, Herentals, Belgium) is an intrinsically thermostable, monocomponent xylanase produced by Thermopolyspora flexuosa expressed in Pichia pastoris and is a beta 1-4, endo-xylanase enzyme belonging to the GH11 family, designed to improve the degradation of dietary fiber to maximize the energy utilization of the diet. Xygest HT has a minimum activity of 3,000,000 U/g on a corn starch-based carrier; the doses, expressed in g/t, correlate with the enzyme activity (U/kg) depicted in

Table 1. Trial design and dosages of the efficacy trials performed in broilers.

Duration (Days)	Number of Treatments	Replicates per Treatment/Broilers per Replicate/Total Number of Broilers	Breed and Sex	Intended Dose (g/ton Xygest HT)	Intended Dose (U/kg)
35	4 (T1, T2, T3, T4)	12/15/720	Ross 308, as hatched	T1: 0	T1: 0
				T2: 10	T2: 30,000
				T3: 15	T3: 45,000
				T4: 30	T4: 90,000

.

2.2. Animals and Housing

The procedures related to animal care used in this study were approved by Ethical Committee branch of the Research Committee of Aristotle University of Thessaloniki (decision number 811/21-01-2020; project code 99821). Animals were reared and treated in compliance with the Directive 2010/63/EU covering the protection of the animals used for experimental or other scientific purposes.

The study took place in a designated poultry house in the area of Galatista located in Chalkidiki prefecture of Greece. The premises belong to Strikos Poultry Enterprises, a company collaborating with the Laboratory of Animal Husbandry of the University of Thessaloniki and are used for experimental purposes under the license of the Greek Veterinary Authority. Broiler chicks were obtained from a commercial hatchery (Koutsos-Tzotzas Hatchery, 20 km of Thessaloniki-Poligiros National Road, Thessaloniki, 57006, Greece) and were orally vaccinated for Gumboro disease (CEVAC TRANSMUNE), Infectious Bronchitis (CEVAC MASS L; CEVAC IBIRD) and Newcastle Disease (CEVAC UNI L). Each pen was provided with one individual plastic feeder (40 cm diameter in basis, 15 kg maximum capacity, with a capacity of up to 70 broilers based on manufacturer’s recommendations) and one bell-type drinker (with a capacity of up to 100 broilers). In each pen (2.0 m length; 1.0 m width; 1.0 m height; basic material wooden beams and plastic wire), 15 mixed sex broilers were allocated, corresponding to a stocking density of 7.5 broilers/m². The facility room had window inlets in each two sides to control day length and entrance of physical light. Heating was provided by a gas heating system comprised of multi-zone installation of brooders using a thermostat placed at the center of the room. Ventilation was controlled by a semi-automated system by opening window inlets and function of mixing fans. Lighting program was managed according to Aviagen lightning recommendations. Specifically, a long day length of 23 h light and 1 h dark in the early stages of growth—up to 7 days of age was provided. Then according to recommendations, a minimum 4–6 h of darkness was provided from 7 days of age onwards. Temperature and humidity of the poultry house were daily monitored during the experiment.

2.3. Experimental Design

Seven hundred and twenty (720) one-day old mixed sex broiler chickens (Ross 308) were randomly allocated to four (4) dietary treatments comprised 12 pens each (48 pens in total). Broilers were not blocked for allocation to treatments either based on weight or sex (males, females). Each pen comprised one replicate. The experimental setup is presented in Table 1.

2.4. Diets

The diets were fed for a total period of 35 days and were provided in three phases as starter, grower, and finisher mash. The starter diets were fed from 0–14 days, the grower diets from 15–28 days, and the finisher diets from 29–35 days. Diet 1 (T1) consisted of a control diet. Diet 2 (T2) consisted of the control diet with 10 g/t Xygest HT. Diet 3 consisted of the control diet supplemented with 15 g/ton Xygest HT. The last diet (T4) was the control diet plus 30 g/ton Xygest HT. All birds were fed ad libitum. All groups received the same basal compound feed, which was mainly based on corn, wheat, and soybean meal as in the control treatment.

Table 2. Composition of the diets; ingredients % used in the studies and the calculated nutrient content.

Ingredient	Starter	Grower	Finisher
Corn	15.0	10.0	10.0
Soybean Meal 46%	32.6	28.1	20.8
Wheat	41.4	49.1	55.0
Rapeseed meal	4.0	5.0	6.0
Soybean oil	3.4	4.7	5.5
MCP	0.7	0.5	0.3
Limestone	1.4	1.2	1.1
Lysine HCl	0.3	0.3	0.3
DL-Methionine	0.4	0.3	0.3
L-Threonine	0.2	0.1	0.1
L-Valine	0.06	0.01	0.03
NaCl	0.2	0.2	0.2
Sodium Bicarbonate	0.2	0.2	0.2
Mineral-Vitamin Premix	0.3	0.3	0.3
Ronozyme HiPhos (Phytase)	0.02	0.02	0.02
Total	100.0	100.0	100.0
Provision	(%)	(%)	(%)
AME poultry AVIAGEN, (Kcal/kg)	2949.9	3049.8	3150.2

shows the ingredients used in the study and the calculated nutrient content during the three phases of the study. All diets were manufactured before the onset of the experiment. The experimental feeds were manufactured at the feed mill of Strikos Poultry Enterprises. To avoid contamination between treatments, feeds without the test feed additive were prepared before feeds supplemented with the new xylanase (lot number 190703, produced at CRVAB, Chifeng, China). The latter were based on the control diets and were made in increasing concentrations. The basal feeds were produced with no xylanase, no antibiotics, no anti-coccidian drug or coccidiostats. Water was available for the chickens ad libitum. Except for the test product, the animals did not receive any other similar product for the whole study period.

At the ILVO institute in Belgium, diets were characterized (data presented in

Table 3. Substrate characterization in the control diet.

Ingredient	Amount (%)
Moisture	9.61
Crude protein	18.04
Crude fat	5.63
Crude ash	13.50
starch	35.24
Sugars	3.64
NDF	9.23
ADF	5.09
ADL	0.94
NSP	14.34
Hemicellulose	4.14
Cellulose	4.15

) by the following approach: NSP = 100-moisture–crude protein–crude fat–crude ash–starch–sugar. Then, as the NSP are a heterogenic fraction, composed from cell membranes and pectines, these two fractions were separated by determination of Neutral Detergent Fiber (NDF). NDF is a factor for all cell membrane fractions. Then, by the calculation of NSP minus NDF, an indication of the pectines can be obtained. The fraction of the cell membranes was then split in hemicellulose, cellulose, and lignin by Acid Detergent Fiber (ADF) and Acid Detergent Lignin (ADL) determination. The difference between NDF and ADF is hemicellulose and the difference between ADF and ADL is a measure for cellulose.

2.5. Measurements

2.5.1. Enzyme Activity Recovery in Feed Samples

Feed samples from each treatment were provided to Kemin Europa N.V. for recovery of xylanase. More specifically, for the determination of the xylanase activity in feed, a slightly modified version of a commercially available test kit (xylazyme AX Tablets from Megazyme International Ireland) was used. Xylazyme AX tablets, containing dye-labelled cross-linked wheat xylan polymer as a substrate for enzymatic action, were suspended in aqueous feed extracts. The extracts were incubated with the xylazyme tablets at pH 4.8 using a citrate-phosphate buffer for 15 min at 50 °C. The xylan was hydrolyzed by the xylanase present in the extract, liberating color into the solution. The content of xylanase is finally determined by colorimetry at 585 nm using a calibration curve prepared with feed samples supplemented with a reference xylanase enzyme of known activity, available from the Applicant upon request, undergoing a similar procedure.

2.5.2. Visualization of Hydrolysis Products of Wheat Bran

Chromatographic analysis of the in vitro reaction products of xylanase on wheat bran was performed using thin layer chromatography (TLC). Enzyme (20 U/mL) and wheat bran (1%) were mixed and incubated for 30 min at pH 3.0 by 40 °C. Then, the mixture was incubated for 2 h at pH 6.8 by 40 °C, followed by a boiling and centrifugation step. The reaction mixture (0.01 mL) was applied on silica gel plates (G-60, 10 × 15 cm) and subjected to two sequential ascending chromatography runs using 3:2:1 (v/v) ethyl acetate: acetic acid: water as the solvent system. After air drying the plate, spots developed by spraying with a solution of 0.5% thymol in95% ethanol + 5 mL concentrated sulfuric acid. XOS (X2-X4) standards and AXOS (A3X,XA3XX/XA2XX) standards were used for detection.

2.5.3. Viscosity and pH of Intestinal Digesta

The homogeneous content of the jejunum and the ileum, from each bird were filled in separate laboratory tubes (15 mL). The tubes with homogeneous content from each anatomical part of intestine per bird were centrifuged at 3000× g for 45 min in order to separate the feed particles from the liquid phase. Supernatants (0.5 mL) from each tube were taken and the viscosity was measured in a Brookfield LDV-II+ PRO Digital Viscometer (Brookfield Engineering Laboratories, Stoughton, MA, USA). Two readings were taken from each tube and were represented in units of centipoise (cP). The digesta of the duodenum, jejunum, ileum, and cecum from each bird were immediately collected in separate tubes (15 mL) and vortexed, in order to obtain a homogenous content from each anatomical part of intestine per bird. The pH of the duodenum, jejunum, ileum, and cecum from each bird was measured using a digital pH-meter (pH 315i, WTWWissenschaftlich-TechnischeWerkstätten, Weilheim, Germany).

2.5.4. Performance

Zootechnical performance parameters were recorded throughout the experimental period. All birds were weighed on a pen basis at 1, 7, 14, 21, 28, and 35 days of age. Feed consumption per pen was estimated for the day intervals 1–7, 8–14, 15–21, 22–28, and 29–35. The average body weight (BW; g), average daily gain (BWG; g), average daily feed intake (ADFI; g) and feed conversion ratio (FCR; g feed/g gain) were calculated for periods 1–7 days, 8–14 days, 15–21 days, 22–28 days, 29–35 days and for the overall study (1–35 days). Bird health was examined daily in the pens and any variation in appearance and/or behavior was recorded. Mortality was monitored daily. The animals that died or were culled during the study (9 for T1, 10 for T2, 1 for T3, 9 for T4) were weighed and necropsied by a veterinary pathologist within 12 h after death/culling.

2.5.5. Carcass Measurements and Internal Organ Weights

At the end of the trial (D35), birds were randomly selected from each pen (replication) and were selected, euthanized, and directly taken to perform the following measurements: carcass yield, breast meat yield, weight of the abdominal fat pad, weight of the liver, weight of the heart, weight of the gizzard, weight of the kidney, weight of the bursa, weight of the thymus, and weight of the spleen. In total n = 24 per treatment for live weight, carcass weight, breast, legs, liver, heart, gizzard, and intestine; whereas n = 12 per treatment for kidneys, bursa of Fabricius, spleen, and thymus birds. The relative weight of internal organs was calculated as a ratio by dividing the organs weight by the birds live body weight (g/kg of body weight).

2.5.6. Foot Pad Lesion Scoring

At day 35 of the experiment, the foot pad area was evaluated after taking pictures of birds’ left and right feet. Here, 12 birds per treatment were evaluated. The lesions were scored with a 1–5 foot pad dermatitis scale based on the scoring scales described by Kaukonen et al. (2016) [28]. Specifically, the foot pads were scored as follows: score 1: no lesion-healthy foot pad; score 2: small (≤1 cm) superficial single or several small superficial lesions; score 3: large (>1 cm) mild, superficial lesion; score 4: Small, severe, and deep lesions with dark crust and loss of papilla structure; score 5: Large (>1 cm), severe lesions with dark crust and loss of papilla structure. Afterwards, the extend of foot pad lesions was quantified. Both foot pads from all broilers were photographed from the same distance. On every digital photograph two areas of interest (AOI) were measured with the use of the image analysis software ImageJ [29], delineating the surface corresponding to a. the metatarsal pad, the first digital pads of the second, third, and fourth toes, and the lateral and intermediate interdigital webs (Figure 1A), b. the lesion (Figure 1B). Subsequently the ratio (quotient) of lesion area to the paw area was calculated and registered.

2.6. Statistical Analysis

The pen (replicate) was the experimental unit. Each treatment had 12 pens (with 15 chickens per pen). Performance parameters were evaluated per pen (replicate). For carcass measurements and internal organ weights, each broiler was the experimental unit. The effect of dietary treatments on performance parameters of broilers in the present study was analyzed with one-way ANOVA using SPSS 25.0 (BM SPSS Statistics for Windows, Version 25.0. Armonk, NY, USA: IBM Corp.). The dietary treatment groups were included as fixed factors in the statistical model. Post-hoc comparisons between treatments were investigated by Tukey’s test. The average values including the standard deviation of the mean were calculated for every examined parameter. Statistical analysis of viscosity, pH and foot pad lesion data were carried out using ANOVA and multiple comparisons between treatment means (Tukey’s test) with the use of GraphPad Prism (version 9.1.2 for Windows^®, GraphPad Software, San Diego, CA, USA). The level of significance was set at p < 0.05.

3. Results

3.1. Enzyme Activity Recovery in Feed Samples

The results corroborated that the new xylanase had been added correctly to the diets according to specifications in the trial protocol as presented in

Table 4. Intended and measured xylanase enzyme activity in the different feed samples.

Treatment	Phase	Intended Xylanase Activity	Measured Xylanase Activity
Control	Starter	0 U/kg	0 U/kg
	Grower
	Finisher
T2	Starter	30,000 U/kg	27,675 U/kg
	Grower		35,479 U/kg
	Finisher		31,271 U/kg
T3	Starter	45,000 U/kg	44,557 U/kg
	Grower		51,297 U/kg
	Finisher		41,104 U/kg
T4	Starter	90,000 U/kg	92,792 U/kg
	Grower		84,059 U/kg
	Finisher		82,425 U/kg

.

3.2. Visualization of Hydrolysis Products of Wheat Bran

In Figure 2, it has been demonstrated that oligosaccharide size changes in response to xylanase inclusion. Here, the predominance of XOS and AXOS as hydrolysis products was observed (Figure 2), which indicates that the xylanase internally cleaves the xylan molecules. Thereby, it releases oligosaccharides of xylose and arabinose as major products which could serve as catalyst for viscosity reduction in the intestinal tract.

3.3. Viscosity and pH of Intestinal Digesta

In the jejunum, there was a drop in viscosity of 35% for T4 compared to the control treatment (p < 0.05) (Figure 3). The lowest viscosity was noted in the T4 group, and the highest viscosity was observed in the T1 group. Also in the ileum, viscosity differences were statistically significant between groups as revealed by one-way ANOVA analysis (p = 0.05). Based on Tukey’s post hoc test, there was a drop in viscosity of 18% for T2, 26% for T3 and 14% for T4 compared to the control treatment.

The pH measurements of intestinal content showed that the pH of the duodenum and cecum was not affected by dietary xylanase supplementation. However, in the jejunum, the T3 treatment reduced significantly the pH compared to the other treatments (p < 0.005). In the ileum, T3 group showed the lowest pH compared to the other treatment groups, while T2 and T4 groups also showed lower intestinal pH value compared to the control group, as shown in Figure 4.

3.4. Performance

The body weight (BW) at days 1, 7, 14, 21, 28, and 35 is shown in

Table 5. Effects of different levels of xylanase enzyme supplementation on body weight (g) of broilers at different growth stages (days 1, 7, 14, 21, 28, and 35) (n = 12/treatment).

Days	Treatment					p-Value
	T1	T2	T3	T4	SEM
1	44.5	44.4	44.4	44.1	0.27	0.544
7	161.6 b	174.8 a	171.4 a	169.6 a	3.45	0.004
14	402.5 c	434.3 a,b	429.6 a,b	414.9 b,c	10.18	0.013
21	803.3	859.3	836.4	839.7	26.62	0.221
28	1281.5 b	1348.7 a	1325.2 a,b	1285.8 b	25.58	0.033
35	1913.6 b	2039.3 a	1984.5 a,b	1933.5 b	41.02	0.017

T1: control-no enzyme; T2: 30,000 U/kg enzyme activity; T3: 45,000 U/kg enzyme activity; T4: 90,000 U/kg enzyme activity. Body weight = BW. Values are means. SEM = standard error of the mean. ^a,b,c Means within the same row with different superscripts are significantly different at p < 0.05.

. The birds of all animals treated with the new xylanase had increased BW at the end of the first week (day 7) compared to the counterparts (p < 0.05). On day 14, birds of the T2 and T3 groups were heavier compared to birds of the control group (0 U/kg) (p < 0.05). At the end of the experimental period birds of the T2 group were heavier compared to birds of the control group (p < 0.05).

The BWG of birds in all experimental groups during each week, as well as during the 1–14, 15–28, 29–35, and 1–35-day periods is shown in

Table 6. Effects of different levels of xylanase enzyme supplementation on average daily gain (g/day) of broilers at different growth periods (days 1–7, 8–14, 15–21, 22–28) (n = 12/treatment).

Days	Treatment					p-Value
	T1	T2	T3	T4	SEM
1–7	16.7 b	18.6 a	18.2 a	17.9 a	0.48	0.003
8–14	34.4 c	37.1 a,b	36.9 a,b	35.0 b,c	1.10	0.044
15–21	57.3	60.7	58.1	60.7	3.06	0.571
22–28	68.3	69.9	69.8	63.7	3.16	0.184
29–35	90.3	98.7	94.2	92.5	3.82	0.178
1–14	25.64 c	27.9 a,b	27.5 a,b	26.5 b,c	0.72	0.011
15–28	62.8	65.3	64.0	62.2	1.51	0.191
1–35	53.4 b	57.0 a	55.4 a,b	54.0 b	3.82	0.017

T1: control-no enzyme; T2: 30,000 U/kg enzyme activity; T3: 45,000 U/kg enzyme activity; T4: 90,000 U/kg enzyme activity. Average daily gain = BWG. Values are means. SEM = standard error of the mean. ^a,b,c Means within the same row with different superscripts are significantly different at p < 0.05.

. For the 1–7-day period all treatment groups supplemented with the new xylanase exhibited higher BWG compared to birds in the control group (p < 0.05). During the period between days 8–14 and days 1–14, the highest value of BWG was observed in birds fed either 30,000 U/kg (T2) or 45,000 U/kg (T3) xylanase compared to those from the control group (p < 0.05). For the whole experimental period, broilers supplemented with the lowest dose (T2) had higher BWG compared to those of the control group and to T4 group (p < 0.05).

The ADFI of birds in all experimental groups during each week, as well as during the 1–14, 15–28, and 1–35-day periods is shown in

Table 7. Effects of different levels of xylanase enzyme supplementation on average daily feed intake (g/day) of broilers at different growth periods (days 1–7, 8–14, 15–21, 22–28, 29–35 and 1–14, 15–28, 1–35) (n = 12/treatment).

Days	Treatment					p-Value
	T1	T2	T3	T4	SEM
1–7	21.9	22.1	22.7	22.3	1.24	0.916
8–14	55.0	52.2	53.5	54.5	1.71	0.386
15–21	83.0	83.0	83.6	82.0	5.05	0.991
22–28	105.9	108.3	105.4	102.2	2.32	0.083
29–35	155.4 b	163.1 a	158.2 a,b	151.2 b	3.38	0.009
1–14	38.4	37.1	38.1	38.4	0.67	0.203
15–28	94.5	95.7	94.5	92.1	2.78	0.628
1–35	84.2	85.7	84.7	82.4	3.38	0.009

T1: control-no enzyme; T2: 30,000 U/kg enzyme activity; T3: 45,000 U/kg enzyme activity; T4: 90,000 U/kg enzyme activity. Average daily feed intake = ADFI. Values are means. SEM = standard error of the mean. ^a,b Means within the same row with different superscripts are significantly different at p < 0.05.

. The ADFI in birds supplemented with 30,000 U/kg xyalanse was higher only during the period 29–35 days of age compared to birds supplemented with either 0 or 90,000 U/kg (p < 0.05). No other significant difference was detected for ADFI between treatments.

The FCR of birds in all experimental groups during each week, as well as during the 1–14, 15–28, and 1–35 days periods is shown in

Table 8. Effects of different levels of xylanase enzyme supplementation on feed conversion ratio of broilers at different growth periods (days 1–7, 8–14, 15–21, 22–28, 29–35 and 1–14, 15–28, 1–35) (n = 12/treatment).

Days	Treatment					p-Value
	T1	T2	T3	T4	SEM
1–7	1.35	1.21	1.30	1.27	0.06	0.134
8–14	1.58 a	1.42 c	1.44 b,c	1.56 a,b	0.07	0.032
15–21	1.48	1.39	1.44	1.42	0.09	0.775
22–28	1.57	1.56	1.51	1.73	0.16	0.590
29–35	1.78	1.70	1.69	1.64	0.06	0.153
1–14	1.51 a	1.34 c	1.40 b,c	1.46 a,b	0.04	0.001
15–28	1.56	1.50	1.48	1.52	0.04	0.307
1–35	1.62 a	1.54 b	1.53 b	1.55 b	0.03	0.014

T1: control-no enzyme; T2: 30,000 U/kg enzyme activity; T3: 45,000 U/kg enzyme activity; T4: 90,000 U/kg enzyme activity. Feed conversion ratio = FCR. Values are means. SEM = standard error of the mean. ^a,b,c Means within the same row with different superscripts are significantly different at p < 0.05.

. FCR was lowest in birds supplemented with 30,000 and 45,000 U/kg xylanase during the 8–14 days period and for the 1–14 days period (p < 0.05). Regarding the total experimental period (days 1–35), broilers that were fed diets supplemented with the tested product irrespective of the dose had significantly lower FCR compared to those of the control group (p < 0.05).

With regards to mortality, during the experimental period dead broilers per treatment group were: 9 for control, 10 for 30,000 U/kg, 1 for 45,000 U/kg, and 9 for 90,000 U/kg. No significant difference was found between treatments for the number of dead birds (p = 0.4).

3.5. Carcass Measurements and Internal Organ Weights

The average values of carcass measurements and internal organ weights are shown in

Table 9. Effects of different levels of xylanase enzyme supplementation on carcass measurements and absolute internal organ weights of broilers. n = 24 for live weight, carcass weight, breast, legs, liver, heart, gizzard, and intestine; n = 12 for kidneys, bursa of Fabricius, spleen, and thymus.

Parameter	Treatment					p-Value
	T1	T2	T3	T4	SEM
Live weight (g)	2061.8 b	2122.7 ab	2268.9 a	2300.2 a	93.75	0.035
Carcass weight (g)	1841.6 b	1904.8 ab	2044.6 a	2066.0 a	85.84	0.027
Breast (g)	569.4	560.8	624.4	641.7	35.06	0.057
Legs (g)	400.8 b	430.4 ab	455.8 a	449.5 a	19.14	0.023
Liver (g)	46.3 b	51.9 ab	51.3 a	52.0 a	2.65	0.097
Heart (g)	12.3	13.2	13.2	13.3	0.62	0.373
Gizzard (g)	78.1	80.7	80.5	78.3	2.67	0.648
Intestine (g)	173.0	169.1	177.2	181.4	11.46	0.733
Kidneys (g)	11.8 b	11.7 b	13.1 ab	14.0 a	0.86	0.025
Bursa of Fabricius (g)	4.6	4.2	4.9	4.7	0.49	0.496
Spleen (g)	2.2	1.9	2.5	2.4	0.27	0.175
Thymus (g)	3.9	3.7	4.5	4.8	0.61	0.269

T1: control-no enzyme; T2: 30,000 U/kg enzyme activity; T3: 45,000 U/kg enzyme activity; T4: 90,000 U/kg enzyme activity. Values are means ± SD. ^a,b Means within the same row with different superscripts are significantly different at p < 0.05.

. Interestingly, live weight and carcass weight of sampled birds was significantly higher in the treatments supplemented with 45,000 and 90,000 U/kg xylanase compared to the control group (p < 0.05). Similar significant differences were observed for the legs and liver weight (p < 0.05). Similar significant differences were observed for the legs and liver weight (p < 0.05). The weight of kidneys was significantly higher in the treatment supplemented with 90,000 U/kg xylanase compared to the control group and the group supplemented with 30,000 U/kg xylanase (p < 0.05).

3.6. Foot Pad Lesion Scoring

The evaluation of foot pad lesions showed no significant effect of xylanase supplementation on foot pad dermatitis score, as shown in Figure 5.

4. Discussion

The increased content of NSP in broiler diets exerts anti-nutritive effects by increasing digesta viscosity, mainly by the fraction of soluble NSP [30]. Cereals have cell walls that contain up to 15% NSPs, which include soluble and insoluble NSPs [31]. NSPases have been reported to breakdown NSP present within the intact cell wall. Such rupture of the cell wall may increase the digestibility of physically entrapped nutrients [18,31]. The insoluble fraction of NSPs makes up the bulk of the total fiber in diets, and they are considered as a nutrient dilution factor and have little or no effect on nutrient utilization in monogastric animals [32,33]. However, the soluble fractions of NSPs, mainly arabinoxylans in wheat, act as a physical barricade to nutrient digestion and absorption by increasing gut viscosity [13].

For the present study, we explored the impact of a new, intrinsically thermostable, mono-component xylanase in wheat-based broiler diets. For this reason, high NSP diets were formulated to provide sufficient substate for the xylanase to act. The NSP levels were similar or higher than those reported in research studies evaluating the efficacy of xylanases in wheat-based diets [30]. Compared to the control diets, the tested xylanase decreased viscosity and pH at various intestinal segments, improved broiler performance and was beneficial for the carcass traits. It is essential to stabilizing the physico-chemical characteristics of the gut content especially in the case of high viscosity diets, using digestibility enhancers.

In previous studies, xylanase supplementation resulted in a reduction of intestinal viscosity in broilers aged 14 or 28 days when fed high rye diets [34]. This reduction in intestinal viscosity is associated with enhanced intestinal digestion and absorption. Kouzounis et al. (2021) [30] showed that xylanase supplementation in wheat-based diets in broilers improved nutrient digestibility and arabinoxylan fermentability. Barekatain et al. (2013) [35] reported that addition of xylanase to diets containing sorghum distillers’ dried grains with soluble (sDDGS) significantly lowered the concentration of insoluble NSPs and augmented the concentration of free sugars (arabinose and xylose) in the ileal digesta. That study explained that the availability of these free sugars may have provided nutrients to the birds, leading to improved FCR. This research implies that the beneficial effects of xylanase are primarily through the reduction in the viscosity and, secondarily, the release of sugars [24,36]. The release of monosaccharides by exogenous enzymes is through two mechanisms: firstly, the breakdown of NSPs deliberates monosaccharides, and secondly, the breakdown of NSPs releases the starch within the endosperm, which exposes the starch to the endogenous amylase, releasing more glucose.

With regards to intestinal pH, previous studies in broilers fed with wheat-based diets, showed that xylanase supplementation may affect differently gastrointestinal tract’s pH. In the study of Esmaeilipour et al. (2012) [37] xylanase did not affect pH in any part of the gastrointestinal tract. Elsewhere, Engberg et al. (2004) [38] showed that in broilers fed diets with different forms of wheat, xylanase resulted in a reduction of pH in duodenum, jejunum, and cecum. Gao et al. (2008) [23], reported that xylanase caused a reduction of pH value only in cecum, while pH value increased in duodenum, jejunum, and ileum. Our results showed that pH reduction due to xylanase supplementation occurred mainly at the site of jejunum and ileum, which are the two main sites of nutrient digestion and absorption. It has been suggested that a decrease in intestinal pH increases pancreatic secretion of digestive enzymes and the segregation of bile acid for lipid emulsification, which improves digestion and absorption of nutrients [39,40]. It should also be noted that the greatest reduction in pH was achieved by the 45,000 U/kg level of supplementation, while the double dose did not result in any further improvement. The observed effects of xylanase on jejunum and ileum pH coincide with previous studies and could be attributed to an indirect effect on intestinal microbiota. Engberg et al. (2004) [38] showed that xylanase supplementation increased the concentration of lactic acid in ileal contents. Lactic acid production could be related with abundance of beneficial gut microbiota such as Lactobacillus spp. Indeed, recently was shown that xylanase supplementation increased the abundance of Ruminococcaceae, Lachnospiraceae, and Lactobacillus salivarius [41]. The latter authors suggested that xylanase supplementation promoted broiler performance by improving feed efficiency and that these effects may be related to the increased abundance of beneficial gut microbiota [41]. A recent study [31] showed that supplementation of the same enzyme as in the current study in corn-based diets, stimulated Lactobacilli growth. Thus, it can be hypothesized that the pH reduction observed in the current study was mediated by a similar mechanism. However, further investigation is required to clarify these effects in wheat-based diets.

An interesting finding in this study is that supplementation of the enzyme improved broiler growth at their early life stage (period between days 1–7, 1–14, and 8–14). It is known that broiler chicks do not have a well-developed gastrointestinal tract. During the starter phase, broiler chicks cannot efficiently utilize high levels of fiber in the diet and as a result have impaired growth during the first week [42]. Other studies also showed improved body weight and FCR in young chickens after dietary supplementation with exogenous enzymes [43]. Similarly, Santos et al. (2013) [44] showed beneficial growth performance results when xylanase was used as a supplement in rye-based diets for broiler chickens in their early growth stages up to 21 days of life. In the present study, a significant effect was observed on FCR in early growth stages (8–14 days, 1–14 days) in the 30,000 U/kg group. Van Hoeck et al. [27] showed that the supplementation of the same xylanase in corn-based diet significantly improved FCR for the overall study period. The latter study demonstrated also an overall beneficial effect of xylanase, even at 30,000 U/kg, on broilers’ performance and carcass traits. In accordance with other reports [23,26], the data of the present study once more confirmed that the addition of xylanase to wheat-based diets significantly increased the BWG and improved the FCR of broilers at 35 days of age. Munyaka et al. [45] showed increased body weight gain in broilers chickens fed wheat-based diets supplemented with xylanase. Lee et al. (2020) [46] reported that weight gain and feed conversion ratio during the overall study period responded linearly to higher levels of xylanase supplementation. Similar effects were also reported in earlier studies in which broilers’ diets were wheat-based [37,47,48]. Thus, the significant effects observed herein regarding carcass parameters could be attributed to the effect of xylanase on BWG. Moreover, the greater weight of internal organs such as the liver and kidneys, may also be related to the greater metabolic needs in the xylanase supplemented groups. Liver growth is related to a higher metabolic rate and is associated with an increase in the small intestine weight, which stimulates the production of bile acid from the liver needed for the digestion of lipids [40,49].

In this study, xylanase supplementation did not affect the FI of birds, indicating that the improvement in feed efficiency observed is likely to be a result of the improved nutrient utilization. Notably, all experimental groups supplemented with the new xylanase showed improved FCR compared to the control group. These effects could be attributed to an increased utilization of feed ingredients due to a more efficient breakdown of NSP contained in the feed [50,51]. Similarly, Lee et al. (2020) [46] showed improved digestibility of dry matter, gross energy, nitrogen, and soluble non-starch polysaccharides.

The evaluation of foot pad lesions showed no significant effect of xylanase supplementation on foot pad lesions. According to Shepherd et al. (2010) [52], increased concentrations of non-starch polysaccharides in broilers’ diets may cause excreta that can adhere to the foot pads, most probably because of increased intestinal viscosity. Although there was an improvement in intestinal viscosity in the present study, this did not affect positively foot pad lesions. To our knowledge this is one of the few studies that has evaluated foot pad lesions in conjunction with xylanase supplementation in broilers. As foot pad dermatitis is a multifactorial condition, it is necessary to consider other potential interacting factors, besides NSP content of broiler diets. This field warrants further investigation.

5. Conclusions

Dietary supplementation of the new xylanase resulted in lower intestinal viscosity and lower pH. Moreover, supplementation of the new xylanase at 30,000 U/kg resulted in a significant improvement of broiler performance and carcass traits when feeding wheat-based diets. The latter effects were probably mediated by positive effects on nutrient digestibility. Nevertheless, digestibility of nutrients was not evaluated in the present study. Thus, a further evaluation of the effects of the tested xylanase in high-NSP diets is necessary.